Abstract:A characteristic feature of atherosclerosis is its diffuse involvement of arteries across the entire human body. Bone marrow cells (BMC) can be simultaneously transferred with therapeutic genes and magnetic resonance (MR) contrast agents prior to their transplantation. Via systemic transplantation, these dual-transferred BMCs can circulate through the entire body and thus function as vehicles to carry genes/contrast agents to multiple atherosclerosis. This study was to evaluate the feasibility of using in vivo MR imaging (MRI) to monitor BMC-mediated interleukin-10 (IL-10) gene therapy of atherosclerosis.For in vitro confirmation, donor mouse BMCs were transduced by IL-10/lentivirus, and then labeled with a T2-MR contrast agent (Feridex). For in vivo validation, atherosclerotic apoE(-/-) mice were intravenously transplanted with IL-10/Feridex-BMCs (Group I, n = 5) and Feridex-BMCs (Group II, n = 5), compared to controls without BMC transplantation (Group III, n = 5). The cell migration to aortic atherosclerotic lesions was monitored in vivo using 3.0T MRI with subsequent histology correlation. To evaluate the therapeutic effect of BMC-mediated IL-10 gene therapy, we statistically compared the normalized wall indexes (NWI) of ascending aortas amongst different mouse groups with various treatments.Of in vitro experiments, simultaneous IL-10 transduction and Feridex labeling of BMCs were successfully achieved, with high cell viability and cell labeling efficiency, as well as IL-10 expression efficiency (≥90%). Of in vivo experiments, MRI of animal groups I and II showed signal voids within the aortic walls due to Feridex-created artifacts from the migrated BMCs in the atherosclerotic plaques, which were confirmed by histology. Histological quantification showed that the mean NWI of group I was significantly lower than those of group II and group III (P<0.05).This study has confirmed the possibility of using MRI to track, in vivo, IL-10/Feridex-BMCs recruited to atherosclerotic lesions, where IL-10 genes function to prevent the progression of atherosclerosis.

Molecular MRI of hematopoietic stem-progenitor cells: in vivo monitoring of gene therapy and atherosclerosis

Multimodality Molecular Imaging of Stem Cells Therapy for Stroke.

Magnetic Resonance Imaging of Bone Marrow Cell-Mediated Interleukin-10 Gene Therapy of Atherosclerosis

In vivo MR imaging of bone marrow cells trafficking to atherosclerotic plaques.

Mri of Auto-Transplantation of Bone Marrow-Derived Stem-Progenitor Cells for Potential Repair of Injured Arteries

Dual transfer of GFP gene and MGd into stem-progenitor cells: toward in vivo MRI of stem cell-mediated gene therapy of atherosclerosis

Mri of Autotransplantation of Bone Marrow-Derived Stem-Progenitor Cells: Toward Cell-Based Repair of Injured Arteries

Translational applications of molecular imaging in cardiovascular disease and stem cell therapy

Genetic Engineered Molecular Imaging Probes for Applications in Cell Therapy: Emphasis on MRI Approach.

MRI Tracking Stem Cells Transplantation for Coronary Heart Disease.

MRI of intravenously injected bone marrow cells homing to the site of injured arteries.

Applications of magnetic resonance imaging for cardiac stem cell therapy

Visualization and Characterization of Atherosclerotic Plaques by Micro-MRI at 4.7 T In Vivo and 11.7 T Ex Vivo

Molecular imaging in stem cell therapy for spinal cord injury.

Application of Molecular Imaging in Stem Cell Therapy for Ischemic Heart Diseases

Monitoring bone marrow-originated mesenchymal stem cell traffic to myocardial infarction sites using magnetic resonance imaging.

Magnetic Resonance Imaging Permits In Vivo Monitoring Of Catheter-Based Vascular Gene Delivery

Clinical 3.0 T Magnetic Resonance Scanner to Be Used for Imaging of Mouse Atherosclerotic Lesions

MRI in guiding and assessing intramyocardial therapy

Molecular imaging for In vivo tracking of stem cell fate

Molecular imaging nanoprobes and their applications in atherosclerosis diagnosis